Dr. Carter received an MSc in Molecular Biology in 2001 from Queen’s University and an Medical Doctorate from McMaster University in 2004. She completed residency in Medical Genetics at the University of Ottawa in 2009, followed by a clinical fellowship in Developmental Pediatrics at the University of Toronto. She specializes in the genetic evaluation of individuals with neurodevelopmental disorders. She is the Medical Director of CHEO’s Rett syndrome clinic and also co-directs CHEO’s Angelman syndrome clinic. Her research interests include delineation of the phenotypic consequences of chromosomal anomalies and elucidation of the genetic etiologies of autism spectrum disorder and intellectual disabilities.
Melissa Carter
Investigator, CHEO Research Institute
